All Pathways
Hematology & OncologyEmergency

Sickle Cell Vaso-Occlusive Crisis Management (ASH 2020)

Sickle Cell Vaso-Occlusive Crisis Management (ASH 2020): Known sickle cell disease with acute pain → Triage: very severe pain is ATS 2 → Fever ≥38.5 °C:...

Pathway Overview

14 steps

Algorithm Steps

14 total

  1. 01Start

    Known sickle cell disease with acute pain

    Adult or child with SCD (HbSS, HbSC, HbSβ-thalassaemia) and an acute pain episode. Pregnant: involve obstetrics and haematology early.

  2. 02Action

    Triage: very severe pain is ATS 2

    Give the first analgesic within 30 min of triage or 60 min of arrival.

    • ATS 2 (10 min): very severe pain, fever with lethargy, unstable sepsis, stroke signs
    • At least ATS 3 (30 min): moderately severe pain that needs analgesia
    • Full observations: temperature, SpO2, RR, HR, BP, pain score
    • Do not delay analgesia for IV access: use SC or intranasal route
  3. 03Warning

    Fever ≥38.5 °C: possible sepsis, not only VOC

    Functional asplenia: high risk of pneumococcal sepsis. Treat infection and pain together. Looks septic: start the sepsis pathway now.

    • Blood culture, FBC, reticulocytes; urine culture if UTI suspected; CXR if chest signs
    • Child: prompt parenteral 3rd-generation cephalosporin (eg ceftriaxone)
    • Adult: low threshold for IV antibiotics; admit if ≥39.5 °C or looks unwell
  4. 04Action

    Assess while the first dose is prepared

    Look for complications and other causes of pain. Do not delay the first analgesic dose.

    • Usual crisis pain? Atypical pain: look for another cause
    • Opioids taken today, individual care plan, baseline Hb, genotype
    • Chest pain, cough, dyspnoea, SpO2; neuro exam; spleen size vs baseline; priapism
    • FBC, reticulocytes, group and screen; U&E and LFT if jaundiced or dehydrated
    • Ask: transfused in the last 3 weeks? Pregnant? Renal impairment?
  5. 05Action

    Severe pain: opioid within 30 min of triage

    Parenteral opioid, then reassess. Hold the next dose if sedation score ≥2 or RR ≤10/min (adult) or below the normal range for age (child): hypoventilation can trigger acute chest syndrome. Mild to moderate pain: paracetamol plus NSAID; no NSAID if renal impairment, pregnancy, anticoagulant or peptic ulcer.

    • Use the individual care plan if there is one; if not, base the dose on home opioid use
    • Adult without a plan: IV or SC morphine or hydromorphone; dose per local protocol
    • Child: morphine 0.05 mg/kg IV or SC per dose, repeat as needed (max 5-10 mg per dose; max 2.4 mg/kg/day)
    • Child >12 months, no IV: intranasal fentanyl 1.5 microgram/kg (max 100 microgram) first dose
    • Reassess pain, sedation and SpO2 15-30 min after each dose; re-dose or raise dose by 25% until controlled
    • Renal impairment: prefer fentanyl over morphine. Do not use pethidine.
    • Oversedation or slow breathing: stop opioid, support airway, oxygen; naloxone per local protocol
  6. 06Decision

    Red flags present?

    Fever ≥38.5 °C, chest signs or hypoxia, neurological signs, Hb ≥20 g/L below baseline, enlarging spleen or liver, priapism, or looks unwell.

    • Fever ≥38.5 °C or looks septic
    • Acute chest syndrome: chest pain, cough, dyspnoea, hypoxia or new infiltrate
    • Stroke or TIA: focal deficit, severe headache, seizure, reduced consciousness
    • Hb ≥20 g/L below baseline (or <60 g/L), enlarging spleen or liver, low reticulocytes
    • Priapism: ≥4 hours is an emergency
  7. If Yes
    1. 07Action

      Red flag: stroke, chest syndrome or sepsis

      Admit. Call haematology now. Continue analgesia with sedation and SpO2 checks. Transfuse only with haematology, Rh (C, E) and K matched: HbSS, do not raise Hb above 100 g/L; HbSC, expert decides; transfused in the last 3 weeks, blood bank first.

      • Stroke signs: urgent CT, stroke team; transfuse within 2 h of presentation, exchange preferred; no exchange within 2 h and Hb ≤85 g/L: simple transfusion first
      • Adult ischaemic stroke: assess for IV thrombolysis per stroke pathway, in parallel with transfusion. Not in children under 18
      • ACS: IV cephalosporin plus macrolide; oxygen to SpO2 ≥95%; incentive spirometry
      • ACS transfusion: simple if Hb >10 g/L below baseline; urgent exchange and ICU if SpO2 <90% on oxygen, worse distress or spreading infiltrates
      • Fever or sepsis: cultures and IV antibiotics now; sepsis pathway if unstable
    2. 08Action

      Red flag: acute anaemia, sequestration or priapism

      Transfuse only with haematology advice, Rh (C, E) and K matched red cells. Do not overtransfuse: HbSS, do not raise Hb above 100 g/L.

      • Transfused in the last 3 weeks with pain, anaemia or jaundice: possible delayed haemolytic reaction; blood bank and haematology before any transfusion
      • Splenic sequestration with shock: IV fluid bolus, small-volume transfusion; avoid Hb >80 g/L (sequestered cells return)
      • Aplastic crisis (low reticulocytes): transfuse to a safe Hb; droplet precautions (parvovirus B19)
      • Priapism ≥4 h: urgent urology for aspiration; hydration and analgesia
      • Hepatic sequestration or severe intrahepatic cholestasis: urgent haematology; transfusion
    3. 09Outcome

      Admit for ongoing management

      Inpatient haematology care. ICU if organ failure, stroke or worsening acute chest syndrome.

    If No
    1. 10Action

      No red flags: continue VOC care

      Treat as uncomplicated VOC. Recheck red flags at each review.

      • NSAID for 5-7 days with the opioid; avoid if renal impairment, peptic ulcer, anticoagulation or pregnancy
      • Oral fluids; IV only if unable to drink or dehydrated, at maintenance rate: overhydration risks ACS
      • Oxygen only if SpO2 <95% on room air
      • Incentive spirometry while awake; mobilise early; heat and distraction
      • Regular paracetamol; antiemetic and laxative as needed
      • No transfusion or corticosteroids for uncomplicated VOC
    2. 11Decision

      Pain controlled within 6-8 hours?

      Controlled on oral analgesia, afebrile, SpO2 at baseline, drinking, no new red flag.

    3. If Yes
      1. 12Action

        Controlled: plan discharge

        Only if pain is controlled on oral analgesia and there are no red flags.

        • Oral analgesia plan; adjust home opioids to prevent withdrawal; short supply
        • NSAID for 5-7 days if no contraindication; regular paracetamol
        • HbSS or HbSβ0: hydroxyurea via haematology (child from 9 months; adult with ≥3 moderate-severe crises in 12 months). Not in pregnancy
        • Update the individual care plan; arrange haematology follow-up
        • Return now if fever ≥38.5 °C, chest pain, breathlessness, weakness, pallor or priapism
      2. 13Outcome

        Discharge home

        With an analgesia plan, return advice and haematology follow-up.

      If No
      1. 14Action

        Not controlled: admit

        Admit under haematology. Give scheduled opioid or PCA, not only as-needed doses.

        • PCA or scheduled opioid; with a continuous PCA infusion, review long-acting oral opioids (over-sedation)
        • Monitor sedation score, RR and SpO2; hold opioid if sedation ≥2 or RR ≤10/min (child: below age range); naloxone if respiratory depression
        • Daily FBC and reticulocytes; watch for ACS (new chest signs, hypoxia)
        • Incentive spirometry while awake; mobilise early
        • Refractory pain: ketamine infusion 0.1-0.3 mg/kg/h (max 1 mg/kg/h) in an experienced inpatient unit
      2. Path rejoins step 09Shared downstream outcome

Guideline Source

American Society of Hematology 2020 Guidelines for Sickle Cell Disease: Management of Acute and Chronic Pain

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Adult opioid starting doses are not given: use the individual care plan or the local acute pain protocol
  • Acute complications (ACS, stroke, sequestration, priapism) are summarised only: manage with haematology and the specific protocol
  • Infants under 12 months need paediatric haematology advice
  • Does not cover chronic pain, disease-modifying or curative treatment

Contraindicated Populations

pregnancy_without_obstetric_and_haematology_inputinfants_under_12_months_without_paediatric_haematology_input

Applicable Regions

AUNZUSEUGlobal

AU: Triage by the Australasian Triage Scale (ACEM G24). Paediatric doses from the RCH Melbourne guidelines. Discuss every red flag with the on-call haematologist.

EU: Adapt to local opioid rules and local emergency SCD protocols.

US: Triage as ESI 2 (NHLBI 2014). Follow ASH 2020 pain guidelines.

Version 2Next review: 2027-09-30

Frequently Asked Questions

What is the Sickle Cell Vaso-Occlusive Crisis Management (ASH 2020)?

The Sickle Cell Vaso-Occlusive Crisis Management (ASH 2020) is a emergency clinical algorithm for Hematology & Oncology. It provides a structured decision tree to guide clinical decision-making, based on American Society of Hematology 2020 Guidelines for Sickle Cell Disease: Management of Acute and Chronic Pain.

What guideline is the Sickle Cell Vaso-Occlusive Crisis Management (ASH 2020) based on?

This algorithm is based on American Society of Hematology 2020 Guidelines for Sickle Cell Disease: Management of Acute and Chronic Pain (DOI: 10.1182/bloodadvances.2020001851).

What are the limitations of the Sickle Cell Vaso-Occlusive Crisis Management (ASH 2020)?

Known limitations include: Adult opioid starting doses are not given: use the individual care plan or the local acute pain protocol; Acute complications (ACS, stroke, sequestration, priapism) are summarised only: manage with haematology and the specific protocol; Infants under 12 months need paediatric haematology advice; Does not cover chronic pain, disease-modifying or curative treatment. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Sickle Cell Vaso-Occlusive Crisis Management (ASH 2020) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free